HRA Pharma announced that CEO David Wright has resigned. He will be replaced on an interim basis by chief commercial officer Martyn Hilton, effective September 1.

“Given the significant progress HRA has made, along with my personal goals after leading HRA for more than five years, I believe now is the time to step away from the business,” Wright said in a statement.